Previous Article | Next Article ![]()
Infection and Immunity, February 2001, p. 1127-1133, Vol. 69, No. 2
Mycobacteria Research Laboratories,
Department of Microbiology, Colorado State University, Fort
Collins, Colorado 80523
Received 31 July 2000/Returned for modification 3 October
2000/Accepted 14 November 2000
Lung dendritic cells were identified by immunohistochemistry in
lung tissue sections from C57BL/6 mice. Following isolation from the
lungs using CD11c magnetic beads, the flow cytometric analysis of
I-Ab+ and CD11c+ cells indicated a mixed
population of dendritic cells at different stages of maturation, with
most expressing an immature phenotype. When cultured for 7 days with
recombinant murine granulocyte-macrophage colony-stimulating
factor, 99% of cells were CD11c+ and had a morphology
typical of immature dendritic cells. These cells were negative for
CD34, CD14, and CD8 Disease caused by
Mycobacterium tuberculosis continues to be the major cause
of mortality from infectious disease worldwide (2). While
development of new chemotherapy as well as effective administration of
current therapies may provide some reduction in the incidence of
tuberculosis in the near term, in the longer term an effective vaccine
against the disease would be preferred. However, while current
innovation in new vaccine development is encouraging (16, 18,
19), the field is still limited by a lack of precise knowledge
of the host response, especially that regarding early events soon after
exposure to the bacillus.
It is generally believed that the first cell to encounter M. tuberculosis in the lungs is the alveolar macrophage. If the macrophage is unable to kill the bacillus, it is thought that M. tuberculosis then somehow erodes into the
interstitium, where it encounters other macrophages (how this happens
is more a case of speculation [17] than of hard
evidence) and thus establishes a site of infection. An influx of
macrophages, probably of both local and blood-borne origin, then
ensues, thickening the septa and giving rise to a local interstitial pneumonitis.
Acquired immunity is expressed relatively slowly in the lungs (5,
7). The reason for this is unclear, as is the site where the
protective T cells become sensitized. The lymphoid tissues surrounding
the bronchi are potential sites, but for these to be the sites, antigen
has to be physically carried to these tissues due to the lack of
lymphatic drainage to the mouse alveolus.
One type of myeloid cell capable of such an action is the dendritic
cell. In the current study it is shown that CD11c-positive dendritic
cells are well distributed throughout the alveolar region, with most
exhibiting an immature phenotype when isolated and analyzed by flow
cytometry. The study demonstrates that these cells are capable of
phagocytosing live M. tuberculosis bacteria, leading to
the secretion of interleukin-12 (IL-12) and stimulation of CD4 T
cells to produce gamma interferon (IFN- Mice.
Specific-pathogen-free C57BL/6 female mice (Jackson
Laboratories, Bar Harbor, Maine) of 6 to 8 weeks of age were used.
Bacterium.
M. tuberculosis strain H37Rv was grown
from low-passage seed lots in Proskauer-Beck liquid medium containing
0.02% Tween 80 to mid-log phase then aliquoted and frozen at Culture media.
Dendritic cells were cultured in RPMI medium
(cRPMI) consisting of RPMI 1640 medium (Sigma-Aldrich, Ltd., St. Louis,
Mo.) supplemented with 1% glutamine, 0.1 mM nonessential amino acids (Life Technology, Grand Island, N.Y.), 50 µM 2-mercaptoethanol (Sigma-Aldrich), 1% penicillin-streptomycin (Sigma-Aldrich), 10% fetal bovine serum (FBS), and 20 ng of recombinant murine
granulocyte-macrophage colony-stimulating factor (GM-CSF) (Pepro Tech,
Rocky Hill, N.J.) per ml. In some cultures tumor necrosis factor alpha
(TNF-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.1127-1133.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of Murine Lung Dendritic Cells
Infected with Mycobacterium tuberculosis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
antigens but expressed low levels of the myeloid
marker F4/80 and moderate levels of MAC3. All expressed high levels of
CD11a (LFA-1), CD11b (Mac1), and CD54 antigens, with low levels of
class II major histocompatibility complex. Most cells expressed CD80
but only a small percentage of cells were positive for CD40 and CD86.
Both overnight and 7-day cultures of lung dendritic cells were able to
phagocytose Mycobacterium tuberculosis, and this was
associated with the production of interleukin-12 and stimulation of
both naïve and immune T cells to produce gamma interferon.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
). Given the knowledge (1, 25, 28) that dendritic cells are motile and capable of
homing from the peripheral tissues to lymphoid organs, the data support
the hypothesis that dendritic cells that engulf M. tuberculosis play an important role in the transition from
the initial innate response in the lungs to a state of acquired
specific immunity.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C
until use. The viability of the frozen stock was 8.3 × 108 CFU/ml.
) (Pepro Tech) was added during the last 48 h of culture
at a concentration of 10 ng/ml.
Identification of dendritic cells in lung sections from C57BL/6 mice. Lungs from C57BL/6 mice were inflated with 30% OCT (Tissue-Tek, Inc., Torrance, Calif.) in PBS through the trachea. After the lungs were removed from the pulmonary cavity, they were embedded in OCT and frozen in a bath of liquid nitrogen for a few seconds. Sections, 7 µm thick, were cut on a cryostat (Leica, product no. CM 1850), fixed in cold acetone for 10 min, and air dried. These sections were incubated overnight at 4°C with monoclonal antibody (MAb) CD11c (N418) (Serotec, Oxford, United Kingdom), which specifically recognizes dendritic cells.
Bound antibody was detected using biotinylated goat anti-hamster immunoglobulin G (IgG) (BD PharMingen, San Diego, Calif.). Finally, the reaction was developed using alkaline phosphatase linked to avidin and new fuchsin (Biogenex, San Ramon, Calif.) as substrate. Sections were counterstained with Meyer's hematoxylin.MAbs. MAbs specific for CD11c (N418) (Serotec) and CD11c (clone HL3, hamster IgG), CD11a (LFA-1, clone 2D7, rat IgG2a), CD11b (Mac-1, M1/70, rat IgG2a), MAC3 (clone M3/84, rat IgG1), I-Ab (clone 9AFG-120, mouse IgG2a), CD54 (ICAM-1, clone 3E2, hamster IgG), CD40 (clone 3/23, rat IgG2a), CD86 (B7-2, clone GL1, rat IgG2a), CD80 (B7-1, clone 16-10A1, hamster IgG), rat IgG2a, rat IgG2b, rat IgG1, and hamster IgG were purchased from BD PharMingen as direct conjugates to fluorescein isothiocyanate (FITC), phycoerythrin, or biotin. In addition, MAb F4/80 (clone CI:A3-1, rat IgG2a) as direct conjugate to either FITC or phycoerythrin was purchased from Serotec together with its isotype control. Goat F(ab)2 IgG anti-hamster IgG-FITC (Caltag, Burlingame, Calif.) and streptavidin conjugated to peridinin chlorophyll a protein (PerCP; Becton Dickinson, San Jose, Calif.) were used as secondary antibody where necessary.
Lung dendritic cell isolation.
Isolation of lung dendritic
cells was performed by modification of protocols already described by
others (22). Briefly, mice were euthanatized and the
pulmonary cavities were opened. The blood circulatory system in the
lungs was cleared by perfusion through the pulmonary artery with 3 ml
of saline containing 50 U of heparin (Sigma-Aldrich) per ml. Lungs were
aseptically removed and cut into small pieces in cold RPMI medium. The
dissected tissue was then incubated in RPMI medium containing
collagenase XI (0.7 mg/ml; Sigma-Aldrich) and type IV bovine pancreatic
DNase (30 µg/ml; Sigma-Aldrich) for 30 to 45 min at 37°C. The
action of the enzymes was stopped by adding 10 ml of cRPMI, and
digested lungs were further disrupted by gently pushing the tissue
through a nylon screen. The single-cell suspension was then washed and centrifuged at 200 × g. To lyse contaminating red
blood cells, the cell pellet was incubated for 5 min at room
temperature with 5 ml of Gey's solution (NH4Cl and
KHCO3). Cells were then washed with PBS containing 0.5%
FBS, counted, and incubated at the appropriate ratio with MACS CD11c
microbeads (Miltenyi Biotec, Auburn, Calif.) for 15 min at 6 to 12°C.
After being washed again with 15 ml of PBS, cells were diluted in 5 ml
of PBS containing 0.5% FBS. Finally, CD11c+ cells were
separated by passing the antibody-coated cell suspension over a
VS+ column on a SuperMACS magnetic cell separator. Positive
cells were collected by removing the column from the magnetic field and
then flushing it with PBS-0.5% FBS. Macrophages were removed from the
CD11c+ cell population by plastic adherence incubation
overnight at 37°C in a 5% CO2 atmosphere. Thereafter,
cells were washed with RPMI medium and used for further studies or
cultured again for 7 days in cRPMI. Cultures were fed every 48 h.
|
Bone marrow-derived dendritic cells. Bone marrow-derived dendritic cells were prepared using a procedure similar to one described previously (11). Briefly, mice were euthanatized by exposure to CO2 atmosphere and their femurs were dissected out. After trimming the bones at both ends, the marrow was flushed out with cold cRPMI supplemented with 10% FBS. Cells were washed once in cRPMI and incubated at a concentration of 2 × 105 cells/ml in cRPMI. The medium was changed at 48 h and replaced with cRPMI without antibiotics. After 7 days of incubation, dendritic cells were infected with M. tuberculosis as described below for lung dendritic cells.
Cell staining. Lung dendritic cells were isolated as discussed above and cultured either overnight or for 7 days at 37°C and 5% CO2. Cell suspensions of 5 × 105 cells/ml were prepared and 100 µl was centrifuged onto glass slides. To confirm adherent dendritic cell morphology, cells were cultured using Thermovox coverslips (Nalge Nunc International, Naperville, Ill.). Either cells centrifuged onto glass or cells adhered to plastic were stained using the Hema 3 stain set (Biochemical Science, Swedesboro, N.J.).
In vitro infection of lung dendritic cells. Purified lung dendritic cells from overnight or 7-day culture were cultured in 24-well plates at 2 × 105 cells per ml in cRPMI without antibiotics and infected with M. tuberculosis (H37Rv strain) at a ratio of 5 or 10 bacilli per cell. At different times postinfection cells were washed, centrifuged onto glass slides as indicated above, and stained for acid-fast bacilli using Ziehl-Neelsen stain (Becton Dickinson Microbiology Systems, Sparks, Md.) or stained for cell surface markers and analyzed on a flow cytometer.
Flow cytometric analysis. Lung dendritic cells from either overnight or 7-day culture were washed in dRPMI. After blocking Fc receptors by using 1 µg of anti-mouse CD16/CD32 MAb (Caltag) per 106 cells for 10 min on ice, cells were stained for 30 min on ice with purified or directly conjugated antibodies. Where necessary, cells were washed twice in dRPMI and incubated with an immunoglobulin-specific secondary antibody. Cell acquisition was performed on a FACScalibur (Becton Dickinson, Mountain View, Calif.) and data were analyzed using CellQuest software (Becton Dickinson).
Antigen stimulation of dendritic cells. Lung dendritic cells, either from overnight or 7-day culture, were incubated with 100 µl of cRPMI (without GM-CSF) per well in 96-well plates. Cell number per well varied depending on the study: 2 × 104 cells per well were used for stimulation of immune T cells and 5 × 104 cells per well were used for stimulation of naïve T cells. In naïve T-cell stimulation, cells were stimulated with 0, 1, 5, or 10 bacilli per cell or with 0, 10, 25, or 50 µg of culture filtrate protein (CFP) of M. tuberculosis (received from J. Belisle, Mycobacteria Research Laboratories, Department of Microbiology, Colorado State University, under NIH contract no. AI 75320) per ml. For immune T-cell stimulation, cells were stimulated with 0 or 5 bacilli per cell and 25 µg of CFP per ml. Cells and antigens or bacteria were incubated overnight at 37°C in 5% CO2 atmosphere prior to lymphocyte addition.
M. tuberculosis-immune T cells. Twelve mice per experiment were used. Each received 2 × 105 M. tuberculosis bacilli (H37Rv strain) in saline by intravenous injection via a lateral tail vein.
Stimulation of IFN-
production.
The stimulatory activity
of the lung dendritic cells was assessed by coculturing these cells
with either naïve or immune CD4 T cells. Briefly, splenocytes
were prepared as previously described (7) and resuspended
in PBS-0.5% FBS. Cells were incubated with CD4+
microbeads for 15 min at 6°C and then passed over a VS+
column on a SuperMACS magnetic cell separator. The column was removed
from the separator and the cells were collected in PBS-0.5% FBS and
counted. CD4+ T cells at a ratio of 10:1 were overlaid onto
antigen-presenting cells that were previously stimulated with antigens
(as indicated above). The mixed cell cultures were then incubated for
72 h at 37°C and 5% CO2. In addition, IL-2 (Pepro
Tech) at 5 U per well was added to support CD4+ T-cell
proliferation. In some experiments, cultures received 0.1 ng of murine
recombinant IL-12 (Pepro Tech) per ml.
ELISA.
Supernatants were assayed for IFN-
by a sandwich
enzyme-linked immunosorbent assay (ELISA) using MAbs R4.6A2 and
biotinylated XMG1.2 (BD PharMingen) as previously described
(20). IL-12 "total" (p40 and p70) or IL-12 p70 were
detected using the Endogen mouse IL-12 total or IL-12 p70 ELISA.
Sensitivity of the assay for IL-12 total was 12 pg/ml and for IL-12 p70
was <5 pg/ml.
| |
RESULTS |
|---|
|
|
|---|
Identification of dendritic cells in lung tissue from C57BL/6 mice. Lung tissue sections were stained with monoclonal anti-CD11c (Fig. 1a and b). Dendritic cells were present in the airway epithelium, close to the alveolar walls, interstitial spaces, and alveoli of lungs. At higher magnifications, lung dendritic cells showed a typical morphology, including a lobulated nucleus with abundant cytoplasm and small cytoplasmic projections.
Figure 1c shows the morphology of lung dendritic cells after overnight culture. All the cells possessed large lateral nuclei, abundant cytoplasm, and small cytoplasmic projections and were of various sizes. The side panels show a higher magnification of dendritic cells with lateral nuclei and veiled morphology. Some were clearly in a state of mitosis. When the cells were cultured in Thermovox coverslips, their dendritic nature could be more clearly seen, as demonstrated by long cytoplasmic processes and large central nuclei (Fig. 1d). To determine the ability of the harvested cells to engulf M. tuberculosis, lung dendritic cells were infected in vitro with 5 to 10 bacilli per cell. After overnight infection, the cells were centrifuged onto glass slides and stained for acid-fast bacilli. Intracellular bacilli were clearly evident (Fig. 1e).Cell surface marker expression by purified dendritic cells.
Purified lung dendritic cells were analyzed by flow cytometry. After
purification with CD11c microbeads, 80 to 90% of cells were
CD11c+ (Fig. 2). Based upon
cell surface expression of CD11c and I-Ab antigens,
purified lung dendritic cells after overnight culture could be
classified into three populations, as shown in Fig. 2: (i) I-Ab
low, CD11c+ low, FSClow,
SSClow (R1, top right panel); (ii) I-Ab high,
CD11+ low, FSCmid, SSClow (R2,
bottom right panel); and (iii) I-Ab low, CD11c+
high, FSChigh, SSChigh (R3, central
right panel).
|
but expressed low levels of the myeloid marker F4/80 and moderate to
high levels of MAC3 antigens (Fig. 3).
All cells expressed high levels of CD11a, CD11b, CD11c, and antigen
CD54. In addition, most cells expressed CD80, but only a small
percentage of cells were positive for CD40 and CD86.
|
Flow cytometric analysis of infected lung and bone marrow-derived dendritic cells. It has been reported previously that priming of naïve T cells by dendritic cells requires the upregulation of accessory and costimulatory cell surface antigens. To investigate if this occurred following in vitro infection with M. tuberculosis, the cell surface expression of CD11a, CD11b, CD11c, CD54, CD40, CD80, CD86, and I-Ab antigens on uninfected versus expression on M. tuberculosis-infected lung dendritic cells were compared.
The results of this study are shown in Fig. 4. Upregulation of the CD54 molecule and CD11a and CD11b for lung dendritic cells was seen after overnight infection (Fig. 4A). In addition, lung dendritic cells infected for 48 h or cultured in the presence of TNF-
had an upward shift of the
side scatter parameter (SSC) for both populations (Fig. 4B). These
cells also upregulated CD40 and I-Ab antigens (Fig. 4B).
CD80 and CD86 antigens appeared to be upregulated only very late in
infection (96 h) (data not shown). Bone-marrow-derived dendritic cells
infected for 48 h presented the same pattern of upregulation of
antigens as lung dendritic cells, but I-Ab antigens were
consistently upregulated to a higher level in the bone marrow-derived
dendritic cells than in lung dendritic cells (Fig. 4C).
|
IFN-
production by stimulated T cells.
Lung dendritic cells
were infected with M. tuberculosis at a ratio of 0, 1, 2, 5, or 10 CFU per cell and overlaid with purified naïve
CD4+ T cells. After 72 h of culture, supernatants were
assayed for the presence of IL-12 and IFN-
. Figure
5b shows that lung dendritic cells were
capable of stimulating naïve CD4+ T cells to
produce IFN-
in a dose-dependent manner. IL-12 total was also
detected in these cultures in a dose-dependent manner (Fig. 5a), but
IL-12 p70 was not detected by ELISA, indicating either that it was not
present or that the amount present in these cultures was below the
sensitivity levels of the assay.
|
by
naïve CD4+ T cells when cultured with M. tuberculosis-infected lung dendritic cells (data not shown).
We then analyzed whether immune CD4+ T cells obtained by
intravenous inoculation of mice with M. tuberculosis were
also stimulated by in vitro M. tuberculosis-infected lung
dendritic cells. Figure 6 shows that
immune CD4+ T cells produced IFN-
when cultured in the
presence of M. tuberculosis-infected lung dendritic cells or
when cultured with CFP-stimulated lung dendritic cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
The results of this study show that specialized macrophages exhibiting a dendritic morphology and expression of the CD11c cell surface marker (dendritic cells) are distributed widely throughout the mouse lung tissues. Examination of tissue sections stained with an antibody to CD11c indicated that these cells were present in airway epithelia as well as within the interstitial spaces in the alveolar regions, suggesting that these cells are judiciously placed for any interaction with invading pathogens. This distribution has been reported to be similar in both mice and rats (14, 15, 22).
Isolation of these cells from the lung tissues revealed cells that were mostly circular. Compared to the total numbers of cells that could be harvested from the lungs, their numbers were low. Following flow cytometric analysis it was found that the great majority of these dendritic cells had a marker expression that is generally regarded by most studies (21, 27) as an immature phenotype, i.e., CD11cmid to high and major histocompatibility (MHC) class IIlow. A small number of cells, however, expressed high levels of I-A (Fig. 2), which is indicative of a more mature phenotype that is usually associated with dendritic cells that have encountered an antigen and have undergone interactions with lymphocytes (6, 21).
Previous reports (10, 12) have also described lung dendritic cells with high expression of cell surface MHC class II antigens. The bronchus-associated lymphoid tissue contains discrete T- and B-cell areas as well as interdigitating cells (3) and it may be that lung dendritic cells expressing high levels of MHC class II antigens could have interacted with T cells in the bronchus-associated lymphoid tissue and fully matured inside the lungs.
Harvested dendritic cells could be expanded by in vitro culture with
GM-CSF, but most cells retained an immature phenotype. Expression of
F4/80 and MAC3 was observed, but that of the myeloid progenitor marker
CD34 or the lymphoid marker CD14 was not observed. It has also been
suggested elsewhere (23) that a subset of mouse dendritic
cells can be identified by the expression of the
chain of CD8, but
we failed to observe this in the lung dendritic cells (Fig. 3). As
anticipated, all dendritic cells expressed CD80, but only a few were
seen to express CD40 or CD86. It has been demonstrated elsewhere
(27) that this phenotype tends to identify large immature
cells. Lung dendritic cells infected with M. tuberculosis and cultured overnight exhibited little change in the expression of
CD40, CD80, CD86, and I-A antigens. By 48 h postinfection, however,
CD40 and I-A antigens were upregulated. Despite the relative lack of
costimulatory molecules on the overnight culture, these cells were
still able to induce IFN-
secretion by naïve T cells. Presumably, when in an in vivo environment this efficiency is even
higher; in this regard it has been shown elsewhere (4, 13)
that CD40/40L ligation upregulates the expression of CD80 and CD86 on
dendritic cells, increasing the production of IL-12 and leading to
increased IFN-
secretion. Our own findings regarding the addition of
exogenous IL-12 and stimulation of naïve CD4 T cells are in
keeping with this.
Upregulation of MHC class II antigens after infection was consistently higher in bone-marrow-derived dendritic cells than in lung dendritic cells. Since both cells were cultured under the same conditions, it indicates that there are differences between both types of dendritic cells and that the origin of these cells may be an important factor to consider.
As stressed above, however, before dendritic cells can sensitize T cells they first have to reach them. We hypothesize that these cells take up bacilli from the interstitium and find their way to local lymphoid tissues in the bronchial region, eventually leading to the emergence of antigen-specific T cells. The fact that this will take a finite period of time may thus well explain why expression of acquired immunity in the lungs is such a slow event (5, 7).
In keeping with our hypothesis, we have demonstrated here that infected dendritic cells quickly upregulate molecules that will allow them to pass through the extracellular matrix (integrins CD11a and CD11b) as well as cross-blood-vessel endothelial surfaces (CD54), actions that would be fully consistent with these cells acquiring a motile phenotype. This change in phenotype has been seen by others in cultures of blood-derived dendritic cells (8) but not in immortalized dendritic cell lines infected with M. tuberculosis (26). In contrast, in the current study infection of dendritic cells with M. tuberculosis readily increased CD54 expression.
The concept that dendritic cells could be specifically targeted by new tuberculosis vaccine candidates is attractive. However, it is also clear that interactions between dendritic cells and T cells after their carriage of antigen to lymphoid tissues is a complex issue, in that not only are dendritic cells still relatively poorly understood, but the migratory routes of T-cell subsets, which appear to differ depending upon their selective expression of chemokine receptors such as CCR7 (24), also appear to be a very complicated matter.
| |
ACKNOWLEDGMENTS |
|---|
We thank J. Brinks for technical assistance and A. M. Cooper for critically reviewing the manuscript.
This work was supported by NIH grants HL55967 and AI-44072.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Mycobacteria Research Laboratories, Department of Microbiology, Colorado State University, Fort Collins, CO 80523. Phone: (970) 491-5777. Fax: (970) 491-5125. E-mail: iorme{at}lamar.colostate.edu.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Austyn, J. M.
1996.
New insights into the mobilization and phagocytic activity of dendritic cells.
J. Exp. Med.
183:1287 |
| 2. | Bloom, B. R., and R. Widdus. 1998. Vaccine visions and their global impact. Nat. Med. 4(Suppl.):480-484[CrossRef][Medline]. |
| 3. | Breel, M., M. V. de Ende, T. Sminia, and G. Kraal. 1988. Subpopulations of lymphoid and non-lymphoid cells in bronchus-associated lymphoid (BALT) of the mouse. Immunology 63:657-662[Medline]. |
| 4. |
Buka, S.,
E. K. Thomas,
J. Gong, and P. F. Barnes.
2000.
Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis.
Infect. Immun.
68:3002-3006 |
| 5. | Cardona, P. J., A. M. Cooper, M. Luquin, A. Ariza, F. Filipo, I. M. Orme, and V. Ausina. 1999. The intravenous model of murine tuberculosis is less pathogenic than the aerosol model owing to a more rapid induction of systemic immunity. Scand. J. Immunol. 49:362-366[CrossRef][Medline]. |
| 6. | Cella, M., F. Salusto, and A. Lanzavechia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10-16[CrossRef][Medline]. |
| 7. | Cooper, A. M., J. E. Callahan, M. Keen, J. T. Belisle, and I. M. Orme. 1997. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber. Lung Dis. 78:67-73[CrossRef][Medline]. |
| 8. | Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159:635-643[Abstract]. |
| 9. |
Hilkens, C. M. U.,
P. Lainski,
M. de Boer, and M. L. Kapsenberg.
1997.
Human dendritic cells require exogenous interleukin-12 inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype.
Blood
90:1920-1926 |
| 10. | Holt, P. G., S. Haininh, D. J. Nelson, and J. D. Sedgwick. 1994. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153:256-261[Abstract]. |
| 11. |
Inaba, K.,
M. Inaba,
N. Romani,
H. Aya,
M. Deguchi,
S. Ikehara,
S. Maramatsu, and R. M. Steinman.
1992.
Generation of large numbers of dendritic cells from bone marrow cultures supplemented with granulocyte/macrophage colony-stimulatory factor.
J. Exp. Med.
176:1693-1702 |
| 12. |
Masten, B. J., and M. F. Lipscomb.
1999.
Comparison of lung dendritic cells and B cells in stimulating naive antigen-specific T cells.
J. Immunol.
162:1310-1314 |
| 13. | McLellan, A. D., R. V. Sorg, L. A. Williams, and D. N. J. Hart. 1996. Human dendritic cells activate T lymphocytes via a CD40:CD40 ligand-dependent pathway. Eur. J. Immunol. 26:1204-1210[Medline]. |
| 14. |
McWilliam, A. S.,
S. Napoli,
A. M. Marsh,
F. L. Pemper,
D. J. Nelson,
C. L. Pimm,
P. A. Stumbles,
T. N. C. Wells, and P. G. Holt.
1996.
Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli.
J. Exp. Med.
184:2429-2432 |
| 15. | McWilliam, A. S., P. A. Stumbles, and P. G. Holt. 1999. Dendritic cells: biology and clinical applications, p. 123-140. In M. T. Lotze, and A. W. Thomson (ed.), Dendritic cells. Academic Press, San Diego, Calif. |
| 16. | Orme, I. M. 1999. Beyond BCG: the potential for a more effective TB vaccine. Mol. Med. Today 5:487-492[CrossRef][Medline]. |
| 17. | Orme, I. M. 1998. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol. 6:94-97[CrossRef][Medline]. |
| 18. | Orme, I. M. 1999. New vaccines against tuberculosis. The status of current research. Infect. Dis. Clin. N. Am. 13:169-185[CrossRef][Medline]. |
| 19. | Orme, I. M. 1995. Prospects for new vaccines against tuberculosis. Trends Microbiol. 3:401-404[CrossRef][Medline]. |
| 20. | Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:518-525[Abstract]. |
| 21. | Pierre, P., T. J. Sahnnon, E. Gatti, M. Hull, J. Meltzer, A. Mizra, K. Inaba, R. M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-792[CrossRef][Medline]. |
| 22. |
Pollard, A. M., and M. F. Lipscomb.
1990.
Characterization of murine lung dendritic cells: similarities to langerhans cells and thymic dendritic cells.
J. Exp. Med.
172:159-167 |
| 23. |
Pulendran, B.,
J. L. Smith,
G. Caspary,
K. Brasel,
D. Pettit,
E. Maraskovsky, and C. R. Maliszewski.
1999.
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo.
Proc. Natl. Acad. Sci. USA
96:1036-1041 |
| 24. | Sallusto, F., B. Palermo, D. Leing, M. Miettinen, S. Matikainen, I. Julkunen, R. Forster, R. Burgstahler, M. Lipp, and A. Lanzavecchia. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1617-1625[CrossRef][Medline]. |
| 25. | Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296[CrossRef][Medline]. |
| 26. | Tascon, R. E., C. S. Soares, S. Ragno, E. Stavropoulos, E. M. A. Hirst, and M. J. Colston. 2000. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology 99:473-480[CrossRef][Medline]. |
| 27. |
Wilson, H. L.,
K. Ni, and H. C. O'Neill.
2000.
Identification of progenitor cells in long-term spleen stromal cultures that produce immature dendritic cells.
Proc. Natl. Acad. Sci. USA
97:4784-4789 |
| 28. |
Xia, W.,
C. E. Pinto, and R. Kradin.
1995.
The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen.
J. Exp. Med.
181:1275-1283 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|